DiaSys and VLA Enter Into Agreement in Veterinary Testing
07 Juin 2007 - 7:06PM
PR Newswire (US)
Development of new worm egg counting kits WATERBURY, Conn., June 7
/PRNewswire-FirstCall/ -- DiaSys Corporation's (OTC:DYXC) (BULLETIN
BOARD: DYXC) wholly owned subsidiary, DiaSys Europe Limited and the
Veterinary Laboratories Agency (VLA), UK, an internationally
recognized veterinary research and testing laboratory, have entered
into a strategic agreement for the development, validation and
commercialization of worm egg counting test kits. As part of the
agreement, DiaSys has acquired a license to market the test kits
worldwide. Currently, VLA employs the Improved Modified McMaster
Method for worm egg counting, a technique that is considered to be
the 'Gold Standard'. It is used routinely for worm egg counts in
sheep, goats, deer, cattle, pigs, horses and other exotic species
for both research projects and diagnostic samples. The new
DiaSys/VLA Veterinary Helminth Egg Counting Kit is being developed
to replace the current technology and incorporates a filter
assembly that is self-contained and disposable. This will eliminate
both aerosol and contamination problems and will enable a quicker
processing time leading to a more economic test. Validation of the
new kit will be for compatibility with the Improved Modified
McMaster Method using helminth eggs recovered from sheep and cattle
maintained at VLA. "We are very excited about the partnership with
the VLA. The collaboration will create new applications for our
Parasep technology and VLA's worldwide reputation as a leader in
animal health will assist our product development into the growing
market of veterinary testing" said Morris Silverman, DiaSys'
Chairman. VLA's Chief Executive, Steve Edwards, said, "We are very
pleased to be teaming up with the DiaSys Corporation to develop new
parasitological testing kits. The combination of VLA's expertise in
this area and the commitment of DiaSys to develop innovative,
practical solutions to animal health diagnostics should ensure a
successful partnership." As all major livestock species of economic
importance, including companion animals are exposed to challenge
from a broad range of parasites, the development of new diagnostic
kits will contribute to improving animal health. It is estimated
that the losses inflicted on producers at a global level runs into
billions of dollars. About DiaSys: DiaSys Corporation designs,
develops, manufactures and distributes proprietary medical
laboratory equipment, consumables and infectious disease test-kits
to healthcare & veterinary laboratories worldwide.
Headquartered in Waterbury, Connecticut USA, the Company operates
in Europe through its wholly owned subsidiary based in Wokingham,
England and through distributors in South America. DiaSys, Parasep
and Urisep are registered trademarks of DiaSys Corporation. Further
information about DiaSys can be found at http://www.diasys.com/.
About VLA: VLA is an Executive Agency of the Department for
Environment Food and Rural Affairs (Defra) and is a regional
network of 16 laboratories. The Agency is one of the largest
research and diagnostic testing facilities of its kind in the world
and is internationally recognized as a centre of scientific
excellence. It has close international links with research
institutes, universities and commercial companies and acts as an
International Reference Laboratory for a wide range of infectious
and non-infectious diseases in farm animals. Its aim is to
safeguard public and animal health through world-class research and
surveillance of farmed livestock. More information on VLA can be
found at http://www.vla.gov.uk/ This press release contains
forward-looking statements within the meaning of, and made pursuant
to, the safe harbor provisions of the Private Securities Litigation
Reform Act of 1995. The forward looking statements involve known
and unknown risks, uncertainties and other factors which may cause
the actual results, performance or achievements of the Company or
events, or timing of events, relating to the Company to materially
differ from those expressed or implied by such forward looking
statements. DiaSys refers interested parties to its most recent
Annual Report on Form 10-KSB and other SEC filings for a complete
description of, and discussions about, the Company. DATASOURCE:
DiaSys Corporation CONTACT: Jeffrey Aaronson, President of DiaSys
Corporation, +1-203-755-5083; or Steve Edwards, Chief Executive of
Veterinary Laboratories Agency, VLA, +44 1932 341111 Web site:
http://www.diasys.com/ http://www.vla.gov.uk/
Copyright